本页面由Tiger Trade Technology Pte. Ltd.提供服务

BioLine Rx

2.37
+0.04001.72%
盘后2.370.00000.00%16:10 EDT
成交量:6,689.00
成交额:1.58万
市值:1,031.27万
市盈率:-8.29
高:2.53
开:2.32
低:2.30
收:2.33
52周最高:7.77
52周最低:2.28
股本:435.14万
流通股本:417.35万
量比:0.21
换手率:0.16%
股息:- -
股息率:- -
每股收益(TTM):-0.2860
每股收益(LYR):-0.2856
净资产收益率:-11.01%
总资产收益率:-16.11%
市净率:0.57
市盈率(LYR):-8.30

数据加载中...

2020/02/07

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/22

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/05

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/05

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/05

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/25

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/30

[修订]年度报告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/07/02

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/05

[修订]年度报告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/05/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]